Combined iron oxide nanoparticle ferumoxytol and gadolinium contrast enhanced MRI define glioblastoma pseudoprogression

BACKGROUND: Noninvasively differentiating therapy-induced pseudoprogression from recurrent disease in patients with glioblastoma is prospectively difficult due to the current lack of a biologically specific imaging metric. Ferumoxytol iron oxide nanoparticle MRI contrast characterizes innate immunit...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Neuro Oncol
Prif Awduron: Barajas, Ramon F, Hamilton, Bronwyn E, Schwartz, Daniel, McConnell, Heather L, Pettersson, David R, Horvath, Andrea, Szidonya, Laszlo, Varallyay, Csanad G, Firkins, Jenny, Jaboin, Jerry J, Kubicky, Charlotte D, Raslan, Ahmed M, Dogan, Aclan, Cetas, Justin S, Ciporen, Jeremy, Han, Seunggu J, Ambady, Prakash, Muldoon, Leslie L, Woltjer, Randy, Rooney, William D, Neuwelt, Edward A
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2019
Pynciau:
Neuroimaging
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6422439/
https://ncbi.nlm.nih.gov/pubmed/30277536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy160
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg